AVALO THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
AVALO THERAPEUTICS, INC. (AVTX) reported Increase (Decrease) in Accounts Payable of $3.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.99M, a 77.51% increase year-over-year.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $219.00K, a 44.97% decline year-over-year.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$337.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$1.89M, a 263.53% decline year-over-year.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$146.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was -$163.00K.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$2.44M.
- AVALO THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2022 was -$487.00K, a 161.18% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.21M 10-Q · filed 2026-08-06 | $2.87M derived: sum of 3 quarters · filed 2026-08-06 | $981.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $219.00K 10-Q · filed 2026-05-13 | -$118.00K derived: sum of 2 quarters · filed 2026-05-13 | -$2.01M derived: sum of 3 quarters · filed 2026-05-13 | -$325.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$2.23M derived: sum of 2 quarters · filed 2026-03-23 | -$544.00K derived: sum of 3 quarters · filed 2026-08-06 | -$146.00K 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | -$1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$207.00K derived: sum of 2 quarters · filed 2026-08-06 | $191.00K 10-Q · filed 2025-11-06 | -$1.34M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.08M 10-Q · filed 2026-08-06 | $555.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.71M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $398.00K 10-Q · filed 2026-05-13 | -$1.13M derived: sum of 2 quarters · filed 2026-05-13 | $27.00K derived: sum of 3 quarters · filed 2026-05-13 | -$235.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$371.00K derived: sum of 2 quarters · filed 2026-03-23 | -$633.00K derived: sum of 3 quarters · filed 2026-03-23 | -$163.00K 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $895.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.36M 10-Q · filed 2025-11-06 | $1.02M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $208.00K 10-Q · filed 2025-08-07 | -$134.00K derived: sum of 3 quarters · filed 2025-08-07 | -$97.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $470.00K 10-Q · filed 2025-05-12 | $128.00K derived: sum of 2 quarters · filed 2025-05-12 | $165.00K derived: sum of 3 quarters · filed 2025-05-12 | -$4.65M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$305.00K derived: sum of 2 quarters · filed 2025-03-20 | -$5.12M derived: sum of 3 quarters · filed 2025-03-20 | -$2.44M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$4.78M derived: sum of 2 quarters · filed 2024-11-07 | -$2.09M 10-Q · filed 2024-11-07 | -$659.00K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$4.81M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-12 | -$2.13M 10-Q · filed 2024-08-12 | -$696.00K derived: sum of 3 quarters · filed 2024-08-12 | -$1.41M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $2.68M 10-Q/A · filed 2024-07-11 | $4.12M derived: sum of 2 quarters · filed 2024-07-11 | $3.40M derived: sum of 3 quarters · filed 2024-07-11 | $1.81M derived: sum of 4 quarters · filed 2024-07-11 | ||||
| 2022-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $718.00K derived: sum of 2 quarters · filed 2024-03-29 | -$875.00K derived: sum of 3 quarters · filed 2024-03-29 | -$487.00K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | -$717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.31M derived: sum of 2 quarters · filed 2023-11-09 | -$1.92M 10-Q · filed 2023-11-09 | -$2.12M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.21M 10-Q · filed 2023-08-03 | -$1.40M derived: sum of 3 quarters · filed 2023-08-03 | -$85.00K derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $388.00K 10-Q · filed 2023-05-04 | $190.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.51M derived: sum of 3 quarters · filed 2023-05-04 | -$8.15M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.12M derived: sum of 2 quarters · filed 2023-03-29 | -$8.54M derived: sum of 3 quarters · filed 2023-03-29 | $796.00K 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$8.35M derived: sum of 2 quarters · filed 2022-11-07 | $994.00K 10-Q · filed 2022-11-07 | $1.64M derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | -$9.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$324.00K 10-Q · filed 2022-08-04 | $323.00K derived: sum of 3 quarters · filed 2022-08-04 | -$308.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $9.34M 10-Q · filed 2022-05-05 | $9.99M derived: sum of 2 quarters · filed 2022-05-05 | $9.36M derived: sum of 3 quarters · filed 2022-05-05 | $9.19M derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $647.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $16.00K derived: sum of 2 quarters · filed 2022-03-02 | -$152.00K derived: sum of 3 quarters · filed 2022-03-02 | $99.00K 10-K · filed 2022-03-02 | $98.52K 10-K · filed 2021-03-08 | |||
| 2020-09-30 | -$631.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$799.00K derived: sum of 2 quarters · filed 2021-11-09 | -$548.00K 10-Q · filed 2021-11-09 | -$548.04K 10-Q · filed 2020-11-09 | $1.09M derived: sum of 4 quarters · filed 2021-11-09 | |||
| 2020-06-30 | -$168.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $83.00K 10-Q · filed 2021-08-02 | $82.67K 10-Q · filed 2020-08-06 | $1.72M derived: sum of 3 quarters · filed 2021-08-02 | $1.10M derived: sum of 4 quarters · filed 2021-08-02 | |||
| 2020-03-31 | $251.00K 10-Q · filed 2021-05-13 | $250.97K 10-Q · filed 2020-05-07 | $1.89M derived: sum of 2 quarters · filed 2021-05-13 | $1.27M derived: sum of 3 quarters · filed 2021-05-13 | $1.47M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $1.02M derived: sum of 2 quarters · filed 2021-03-08 | $1.22M derived: sum of 3 quarters · filed 2021-03-08 | $1.02M 10-K · filed 2021-03-08 | ||||
| 2019-09-30 | -$619.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$423.00K derived: sum of 2 quarters · filed 2020-11-09 | -$619.67K 10-Q · filed 2020-11-09 | -$709.46K derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$666.00 10-Q · filed 2020-08-06 | -$90.46K derived: sum of 3 quarters · filed 2020-08-06 | -$1.56M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$196.67K 10-Q · filed 2020-05-07 | -$286.46K derived: sum of 2 quarters · filed 2020-05-07 | -$1.76M derived: sum of 3 quarters · filed 2020-05-07 | -$1.98M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$89.79K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$1.56M derived: sum of 2 quarters · filed 2020-03-11 | -$1.78M derived: sum of 3 quarters · filed 2020-03-11 | $82.45K 10-K · filed 2020-03-11 | ||||
| 2018-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$1.69M derived: sum of 2 quarters · filed 2019-11-14 | $172.24K 10-Q · filed 2019-11-14 | $966.00K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.64M 10-Q · filed 2019-08-08 | $2.43M derived: sum of 3 quarters · filed 2019-08-08 | $2.42M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $1.87M 10-Q · filed 2019-05-09 | $2.66M derived: sum of 2 quarters · filed 2019-05-09 | $2.65M derived: sum of 3 quarters · filed 2019-05-09 | $2.38M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $793.76K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $778.97K derived: sum of 2 quarters · filed 2019-03-18 | $510.40K derived: sum of 3 quarters · filed 2019-03-18 | $96.06K 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | -$14.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$283.36K derived: sum of 2 quarters · filed 2018-11-13 | -$697.70K 10-Q · filed 2018-11-13 | -$475.50K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$268.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$682.91K 10-Q · filed 2018-08-09 | -$460.71K derived: sum of 3 quarters · filed 2018-08-09 | -$412.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | -$414.33K 10-Q · filed 2018-05-11 | -$192.14K derived: sum of 2 quarters · filed 2018-05-11 | -$143.43K derived: sum of 3 quarters · filed 2018-05-11 | -$10.84K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $222.19K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $270.91K derived: sum of 2 quarters · filed 2018-04-02 | $403.50K derived: sum of 3 quarters · filed 2018-04-02 | $332.10K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $48.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $181.31K derived: sum of 2 quarters · filed 2017-11-07 | $109.91K 10-Q · filed 2017-11-07 | -$477.02K derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2016-06-30 | $132.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $61.19K 10-Q · filed 2017-08-14 | -$525.73K derived: sum of 3 quarters · filed 2018-04-02 | -$204.04K derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2016-03-31 | -$71.40K 10-Q · filed 2017-05-09 | -$658.33K derived: sum of 2 quarters · filed 2018-04-02 | -$336.63K derived: sum of 3 quarters · filed 2018-04-02 | -$131.02K derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2015-12-31 | -$586.93K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$265.23K derived: sum of 2 quarters · filed 2018-04-02 | -$59.63K derived: sum of 3 quarters · filed 2018-04-02 | -$268.71K 10-K · filed 2018-04-02 | ||||
| 2015-09-30 | $321.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $527.30K derived: sum of 2 quarters · filed 2016-11-08 | $318.22K 10-Q · filed 2016-11-08 | -$68.65K derived: sum of 4 quarters · filed 2017-03-14 | ||||
| 2015-06-30 | $205.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$3.48K 10-Q · filed 2016-08-15 | -$390.34K derived: sum of 3 quarters · filed 2017-03-14 | |||||
| 2015-03-31 | -$209.08K 10-Q · filed 2016-05-16 | -$595.95K derived: sum of 2 quarters · filed 2017-03-14 | ||||||
| 2014-12-31 | -$386.87K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$708.37K 10-K · filed 2017-03-14 | ||||||
| 2014-09-30 | -$321.50K 10-Q · filed 2015-11-13 | |||||||
| 2013-12-31 | $818.39K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |